B. Martin

发表

The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.

P. Smith, R. Mechoulam, D. R. Compton, 1994, The Journal of pharmacology and experimental therapeutics.

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

Z. Vogel, S. Almog, N. Kaminski, 1995, Biochemical pharmacology.

Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs.

B. Thomas, D. R. Compton, R. Razdan, 1995, The Journal of pharmacology and experimental therapeutics.

Discovery and characterization of endogenous cannabinoids.

R. Mechoulam, R. Razdan, B. Martin, 1999, Life sciences.

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

B. Cravatt, A. Lichtman, B. Martin, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.

C. Breivogel, V. Marzo, V. Di Marzo, 2001, Molecular pharmacology.

New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis

M. Cascio, D. Baker, V. Di Marzo, 2006, British journal of pharmacology.

Modeling the cannabinoid receptor: a three-dimensional quantitative structure-activity analysis.

S. Semus, B. Thomas, D. R. Compton, 1991, Molecular pharmacology.

In vivo pharmacological effects of dihydro-β-erythroidine, a nicotinic antagonist, in mice

M. Damaj, S. Welch, B. Martin, 2005, Psychopharmacology.

Activation of the Cannabinoid Type-1 Receptor Mediates the Anticonvulsant Properties of Cannabinoids in the Hippocampal Neuronal Culture Models of Acquired Epilepsy and Status Epilepticus

R. E. Blair, S. Sombati, B. Martin, 2006, Journal of Pharmacology and Experimental Therapeutics.

Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids.

L. Petrocellis, T. Bisogno, V. Di Marzo, 1999, Current medicinal chemistry.

Development of the first potent and specific inhibitors of endocannabinoid biosynthesis.

T. Bisogno, M. Cascio, A. Minassi, 2006, Biochimica et biophysica acta.

Functional diversity among 5-substituted nicotine analogs; in vitro and in vivo investigations.

A. C. Collins, R. Glennon, A. Collins, 2002, European journal of pharmacology.

Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.

D. R. Compton, B. Martin, G. Kunos, 1997, The Journal of pharmacology and experimental therapeutics.

Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.

D. R. Compton, B. Martin, V. Showalter, 1996, The Journal of pharmacology and experimental therapeutics.

Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.

K. Rice, M. Johnson, L. Melvin, 1993, The Journal of pharmacology and experimental therapeutics.

Development of behavioral tolerance to Δ 9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain

B. Martin, M. Abood, C. Sauss, 1993, Pharmacology Biochemistry and Behavior.

Anandamide, an endogenous cannabinoid, has a very low physical dependence potential.

M. Aceto, R. Razdan, B. Martin, 1998, The Journal of pharmacology and experimental therapeutics.

Levels, Metabolism, and Pharmacological Activity of Anandamide in CB1 Cannabinoid Receptor Knockout Mice

C. Breivogel, A. Zimmer, V. Di Marzo, 2000 .

Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.

C. Breivogel, A. Zimmer, V. Di Marzo, 2000, Journal of neurochemistry.

Lobeline: structure-affinity investigation of nicotinic acetylcholinergic receptor binding.

R. Glennon, M. Damaj, B. Martin, 1999, Journal of medicinal chemistry.

Functional and dispositional tolerance develops during continuous cocaine exposure

M. Aceto, B. Martin, E. Johansson, 1992, European Journal of Drug Metabolism and Pharmacokinetics.

Genetic Approaches Identify Differential Roles for α4β2* Nicotinic Receptors in Acute Models of Antinociception in Mice

A. C. Collins, H. Lester, A. Collins, 2007, Journal of Pharmacology and Experimental Therapeutics.

Paradoxical Pharmacological Effects of Deoxy-Tetrahydrocannabinol Analogs Lacking High CB1 Receptor Affinity

J. Liddle, G. Griffin, B. Martin, 2002, Pharmacology.

Effect of Chronic Administration ofR-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone Mesylate (WIN55,212-2) or Δ9-Tetrahydrocannabinol on Cannabinoid Receptor Adaptation in Mice

B. Martin, L. Sim-Selley, 2002, Journal of Pharmacology and Experimental Therapeutics.

Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G‐protein activation

D. Selley, C. Breivogel, A. Zimmer, 2001, Journal of neurochemistry.

Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists

M. Damaj, B. Martin, Sheri D. Grabus, 2006, Psychopharmacology.

The role of fluorine substitution in the structure-activity relationships (SAR) of classical cannabinoids.

R. Razdan, B. Martin, A. Mahadevan, 2007, Bioorganic & medicinal chemistry letters.

Structure–activity relationships for 1′,1′-dimethylalkyl-Δ 8 -tetrahydrocannabinols

John R. Miller, J. Liddle, B. Thomas, 2003 .

A pyridone analogue of traditional cannabinoids. A new class of selective ligands for the CB(2) receptor.

G. Hynd, B. Martin, J. Wiley, 2001, Bioorganic & medicinal chemistry.

Exposure to Marijuana Smoke Impairs Memory Retrieval in Mice

A. Lichtman, B. Martin, F. Niyuhire, 2007, Journal of Pharmacology and Experimental Therapeutics.

In vitro and in vivo effects of cocaine and selected local anesthetics on the dopamine transporter.

B. Martin, J. Woodward, D. Compton, 1995, European journal of pharmacology.

Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and Stroke

R. Tuma, M. Adler, D. Ganea, 2009, Journal of Neuroimmune Pharmacology.

Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide.

B. Martin, G. Kunos, K. Lake, 1995, European journal of pharmacology.

Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock

E. Ellis, B. Martin, G. Kunos, 1997, Nature.

In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity.

J. Lowe, M. Aceto, D. R. Compton, 1996, The Journal of pharmacology and experimental therapeutics.

Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940.

B. Martin, J. Wiley, J. Huffman, 2008, Bioorganic & medicinal chemistry.

Synthesis and pharmacology of 11-nor-1-methoxy-9-hydroxyhexahydrocannabinols and 11-nor-1-deoxy-9-hydroxyhexahydrocannabinols: new selective ligands for the cannabinoid CB2 receptor.

B. Martin, J. Wiley, Karla-Sue C. Marriott, 2006, Bioorganic & medicinal chemistry.

Enantioselective synthesis of 1-methoxy- and 1-deoxy-2'-methyl-delta8-tetrahydrocannabinols: new selective ligands for the CB2 receptor.

B. Martin, J. Wiley, S. Bushell, 2006, Bioorganic & medicinal chemistry.

1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles.

D. Selley, B. Martin, J. Wiley, 2005, Bioorganic & medicinal chemistry letters.

Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists.

G. Hynd, D. Selley, Ming-Jung Wu, 2005, Bioorganic & medicinal chemistry.

Cannabinoid CB2 Receptor Activation Decreases Cerebral Infarction in a Mouse Focal Ischemia/Reperfusion Model

J. Jallo, R. Tuma, M. Adler, 2007 .

Roles of sulfhydryl and disulfide groups in the binding of CP-55,940 to rat brain cannabinoid receptor

B. Martin, J. Hubbard, M. Kalimi, 1993, Molecular and Cellular Biochemistry.

Cellular effects of cannabinoids.

B. Martin, 1986, Pharmacological reviews.

Stereochemical effects of 11-OH-Δ 8-THC-dimethylheptyl in mice and dogs

P. Little, R. Mechoulam, D. R. Compton, 1989, Pharmacology Biochemistry and Behavior.

Tolerance to the antinociceptive effect of epibatidine after acute and chronic administration in mice.

M. Damaj, B. Martin, 1996, European journal of pharmacology.

The β2 but not α7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice

J. Changeux, M. Damaj, B. Martin, 2006, Psychopharmacology.

Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2‐arachidonoylglycerol

R. Pertwee, R. Razdan, B. Martin, 2004, British journal of pharmacology.

Mechanism of action of cannabinoids: how it may lead to treatment of cachexia, emesis, and pain.

B. Martin, J. Wiley, 2004, The journal of supportive oncology.

Structure-activity relationships of indole- and pyrrole-derived cannabinoids.

D. R. Compton, B. Martin, J. Wiley, 1998, The Journal of pharmacology and experimental therapeutics.

Synthesis of bridged analogs of epibatidine. 3-Chloro-5,7,8,9,9a,10-hexahydro-7,10-methanopyrrolo[1,2-b]-2,6-naphthyridine and 2-chloro-5,5a,6,7,8,10-hexahydro-5,8-methanopyrrolo[2,1-b]-1,7-naphthyridine

L. Brieaddy, S. Mascarella, H. Navarro, 2001 .

Pharmacology of novel nicotinic analogs

R. Glennon, M. Damaj, B. Martin, 1996 .

Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement.

A. Lichtman, B. Martin, S. Cook, 1996, The Journal of pharmacology and experimental therapeutics.

Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency.

B. Thomas, D. R. Compton, B. Martin, 1990, The Journal of pharmacology and experimental therapeutics.

The psychoactive plant cannabinoid, Δ9‐tetrahydrocannabinol, is antagonized by Δ8‐ and Δ9‐tetrahydrocannabivarin in mice in vivo

A. Lichtman, R. Pertwee, R. Razdan, 2007, British journal of pharmacology.

Homoazanicotine: a structure-affinity study for nicotinic acetylcholine (nACh) receptor binding.

R. Glennon, M. Damaj, B. Martin, 2002, Journal of medicinal chemistry.

Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs

R. Mechoulam, B. Thomas, L. Melvin, 1991, Pharmacology Biochemistry and Behavior.

Cannabimimetic Properties of Ajulemic Acid

B. Martin, J. Wiley, R. Vann, 2007, Journal of Pharmacology and Experimental Therapeutics.

Physiochemical and pharmacological characterization of a Delta(9)-THC aerosol generated by a metered dose inhaler.

A. Lichtman, B. Martin, P. Byron, 2002, Drug and alcohol dependence.

Precipitated cannabinoid withdrawal is reversed by Δ9-tetrahydrocannabinol or clonidine

A. Lichtman, B. Martin, J. Fisher, 2001, Pharmacology Biochemistry and Behavior.

The pharmacological activity of inhalation exposure to marijuana smoke in mice.

A. Lichtman, B. Martin, D. Wilson, 2001, Drug and alcohol dependence.

Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.

A. Lichtman, H. Loh, B. Martin, 2001, The Journal of pharmacology and experimental therapeutics.

Time course for the induction and maintenance of tolerance to Δ9-tetrahydrocannabinol in mice

C. Bass, B. Martin, 2000 .

O‐1057, a potent water‐soluble cannabinoid receptor agonist with antinociceptive properties

R. Pertwee, L. Stevenson, R. Razdan, 2000, British journal of pharmacology.

Pharmacological evaluation of aerosolized cannabinoids in mice.

A. Lichtman, R. Razdan, B. Martin, 2000, European journal of pharmacology.

Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain.

L. Harris, B. Martin, J. Woods, 1984, The Journal of pharmacology and experimental therapeutics.

Investigation of the role of the phenolic hydroxyl in cannabinoid activity.

D. R. Compton, B. Martin, P. Reggio, 1990, Molecular pharmacology.

3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptor.

Ming-Jung Wu, B. Martin, J. Wiley, 2003, Bioorganic & medicinal chemistry.

Evaluation of Agonist-antagonist Properties of Nitrogen Mustard and Cyano Derivatives of Δ8-Tetrahydrocannabinol

A. Lichtman, Aloke K. Dutta, C. Siegel, 1996, Neuropharmacology.

Affinity of the enantiomers of α- and β-cyclazocine for binding to the phencyclidine and μ opioid receptors

B. Martin, R. Balster, S. Todd, 1990 .

5'-Azido-delta 8-THC: a novel photoaffinity label for the cannabinoid receptor.

A. Makriyannis, A. Howlett, D. R. Compton, 1992, Journal of medicinal chemistry.

Comparison of the ability of opioid analgesics to increase endogenous opioid-like activity in the cerebrospinal fluid of rabbits.

S. Welch, B. Martin, E. Bowman, 1985, Life sciences.

Modulation of the balance between cannabinoid CB1 and CB2 receptor activation during cerebral ischemic/reperfusion injury

M. Zhang, R. Tuma, M. Adler, 2008, Neuroscience.

Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model.

J. Jallo, R. Tuma, M. Adler, 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.

J. Lowe, M. Aceto, B. Martin, 1995, European journal of pharmacology.

Influence of the degree of unsaturation of the acyl side chain upon the interaction of analogues of 1-arachidonoylglycerol with monoacylglycerol lipase and fatty acid amide hydrolase.

R. Pertwee, R. Razdan, B. Martin, 2005, Biochemical and biophysical research communications.

Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.

P. Little, M. Johnson, L. Melvin, 1988, The Journal of pharmacology and experimental therapeutics.

Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding.

Ming-Jung Wu, G. Griffin, B. Martin, 2000, Drug and alcohol dependence.

Nicotine Receptors in the Central Nervous System

B. Martin, 1986 .

Pharmacological characterization of cannabinoids in the elevated plus maze.

M. Green, B. Martin, M. R. Green, 1990, The Journal of pharmacology and experimental therapeutics.

Pharmacological evaluation of dimethylheptyl analogs of delta 9-THC: reassessment of the putative three-point cannabinoid-receptor interaction.

R. L. Barrett, D. R. Compton, R. Razdan, 1995, Drug and alcohol dependence.

Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation.

N. Kaminski, B. Martin, A. R. Schatz, 1992, Molecular pharmacology.

Molecular neurobiology of the cannabinoid receptor.

B. Martin, M. Abood, Mary E. Abood, 1996, International review of neurobiology.

Differential Role of Nicotinic Acetylcholine Receptor Subunits in Physical and Affective Nicotine Withdrawal Signs

J. Changeux, M. Damaj, B. Martin, 2008, Journal of Pharmacology and Experimental Therapeutics.

Reversal of Δ9-tetrahydrocannabinol-induced tolerance by specific kinase inhibitors

C. Bass, S. Welch, B. Martin, 2004 .

Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor.

R. Razdan, B. Martin, S. Batkai, 2003, Molecular pharmacology.

Cannabinoid properties of methylfluorophosphonate analogs.

D. Deutsch, V. Di Marzo, R. Razdan, 2000, The Journal of pharmacology and experimental therapeutics.

Cannabinoid Properties of Methylfluorophosphonate Analogs 1

D. Deutsch, V. Marzo, R. Razdan, 2000 .

Bupropion Is a Nicotinic Antagonist 1

B. Martin, J. Slemmer, M. Imad, 2000 .

The Cannabinoid Delta-9-tetrahydrocannabinol Mediates Inhibition of Macrophage Chemotaxis to RANTES/CCL5: Linkage to the CB2 Receptor

B. Martin, N. E. Buckley, G. Cabral, 2008, Journal of Neuroimmune Pharmacology.

Pyrolysis and volatilization of cocaine.

B. Martin, L. Lue, J. Boni, 1989, Journal of analytical toxicology.

Δ9-Tetrahydrocannabinol-Induced Apoptosis in the Thymus and Spleen as a Mechanism of Immunosuppression in Vitro and in Vivo

M. Nagarkatti, P. Nagarkatti, B. Martin, 2002, Journal of Pharmacology and Experimental Therapeutics.

Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Epibatidine analogues.

L. Brieaddy, H. Navarro, F. Carroll, 2001, Journal of medicinal chemistry.

Characterization and autoradiographic localization of the cannabinoid binding site in rat brain using [3H]11-OH-delta 9-THC-DMH.

B. Thomas, B. Martin, X. Wei, 1992, The Journal of pharmacology and experimental therapeutics.

The Endocannabinoid System and the Therapeutic Potential of Cannabinoids

B. Martin, 2007 .

Synthesis and pharmacology of 1-alkyl-3-(1-naphthoyl)indoles: steric and electronic effects of 4- and 8-halogenated naphthoyl substituents.

B. Martin, J. Wiley, V. Smith, 2012, Bioorganic & medicinal chemistry.

Synthesis and pharmacology of 1-methoxy analogs of CP-47,497.

B. Martin, J. Wiley, D. Hurst, 2010, Bioorganic & medicinal chemistry.

Synthesis, nicotinic acetylcholine receptor binding, antinociceptive and seizure properties of methyllycaconitine analogs.

F. Ivy Carroll, H. Navarro, M. Damaj, 2007, Bioorganic & medicinal chemistry.

1-Methoxy-, 1-deoxy-11-hydroxy- and 11-hydroxy-1-methoxy-Delta(8)-tetrahydrocannabinols: new selective ligands for the CB2 receptor.

John R. Miller, B. Martin, J. Wiley, 2002, Bioorganic & medicinal chemistry.

Separation of cannabinoid receptor affinity and efficacy in delta‐8‐tetrahydrocannabinol side‐chain analogues

G. Griffin, R. Razdan, B. Martin, 2001, British journal of pharmacology.

Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system.

S. McAllister, G. Griffin, B. Martin, 1999, European journal of pharmacology.

An investigation into the structural determinants of cannabinoid receptor ligand efficacy

G. Griffin, R. Razdan, B. Martin, 1999, British journal of pharmacology.

Synthesis and binding of 6,7,8,9-tetrahydro-5H-pyrido[3,4-d]azepine and related ring-opened analogs at central nicotinic receptors

R. Glennon, M. Damaj, B. Martin, 1999 .

Synthesis, receptor binding and QSAR studies on 6-substituted nicotine derivatives as cholinergic ligands

R. Glennon, M. Damaj, B. Martin, 1999 .

1-Bromo-3-(1',1'-dimethylalkyl)-1-deoxy-Δ(8)-tetrahydrocannabinols: New selective ligands for the cannabinoid CB(2) receptor.

D. Selley, B. Martin, J. Wiley, 2010, Bioorganic & medicinal chemistry.

Preclinical Pharmacological and Brain Bioassay Systems for CB1 Cannabinoid Receptors

B. Martin, J. Wiley, 2009 .

1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: new high affinity ligands for the cannabinoid CB1 and CB2 receptors.

B. Martin, J. Wiley, L. Padgett, 2006, Bioorganic & medicinal chemistry letters.

Synthesis of novel 5-substituted pyrazole derivatives as cannabinoid antagonists

R. Razdan, B. Martin, A. Mahadevan, 2005 .

Differential Effects of Δ9-Tetrahydrocannabinol and Methanandamide in CB1 Knockout and Wild-Type Mice

B. Martin, J. Wiley, Cassandra Y. Baskfield, 2004, Journal of Pharmacology and Experimental Therapeutics.

Resorcinol derivatives: a novel template for the development of cannabinoid CB(1)/CB(2) and CB(2)-selective agonists.

R. Razdan, B. Martin, A. Mahadevan, 2002, The Journal of pharmacology and experimental therapeutics.

Structure-Activity Relationships of Indole-and Pyrrole-Derived Cannabinoids 1

D. R. Compton, B. Martin, J. Wiley, 1998 .

Synthesis, pharmacology, and molecular modeling of novel 4-alkyloxy indole derivatives related to cannabimimetic aminoalkyl indoles (AAIs).

Aloke K. Dutta, B. Thomas, D. R. Compton, 1997, Bioorganic & medicinal chemistry.

1-Alkyl-3-(1-naphthoyl)pyrroles: A New Class of Cannabinoid.

D. R. Compton, B. Martin, J. Huffman, 1995 .

Pharmacological evaluation of halogenated Δ 8-THC analogs

A. Makriyannis, D. R. Compton, B. Martin, 1991, Pharmacology Biochemistry and Behavior.

Significance of cannabinoid CB1 receptors in improgan antinociception.

R. Razdan, B. Martin, M. Wentland, 2007, The journal of pain : official journal of the American Pain Society.

Agonist-antagonist characterization of 6'-cyanohex-2'-yne-delta 8-tetrahydrocannabinol in two isolated tissue preparations.

R. Pertwee, G. Griffin, D. R. Compton, 1996, European journal of pharmacology.

Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol.

L. Gold, D. R. Compton, B. Martin, 1992, The Journal of pharmacology and experimental therapeutics.

The effects of delta9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors.

C. Breivogel, M. Aceto, B. Martin, 2003, European journal of pharmacology.

Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation.

B. K. Parekh, C. Breivogel, B. Martin, 2003, European journal of pharmacology.

Effects of anandamide (endogen cannabinoid) on anterior pituitary hormone secretion in adult ovariectomized rats.

B. Martin, T. Wenger, B. Tóth, 1995, Life sciences.

Evaluation of cAMP involvement in cannabinoid-induced antinociception.

A. Lichtman, S. Welch, B. Martin, 1995, Life sciences.

Spinal mechanisms ofΔ9-tetrahydrocannabinol-induced analgesia

B. Martin, Peter B. Smith, 1992, Brain Research.

Spinal and supraspinal components of cannabinoid-induced antinociception.

A. Lichtman, B. Martin, 1991, The Journal of pharmacology and experimental therapeutics.

In vivo characterization of a novel inhibitor of CNS nicotinic receptors.

R. Papke, M. Damaj, B. Martin, 2005, European journal of pharmacology.

Assessment of the role of CB receptors in cannabinoid 1 anticonvulsant effects

B. Martin, J. Wiley, R. Delorenzo, 2016 .

Thyrotropin releasing hormone: Antagonism of pentobarbital in rodents

B. Cooper, G. Breese, N. Plotnikoff, 1974 .

Medical marijuana—moving beyond the smoke

B. Martin, 2002, The Lancet.

Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality

B. Cravatt, A. Lichtman, B. Martin, 2007, Psychopharmacology.

Novel, potent THC/anandamide (hybrid) analogs.

B. Thomas, R. Razdan, B. Martin, 2007, Bioorganic & medicinal chemistry.

Δ9-Tetrahydrocannbinol Accounts for the Antinociceptive, Hypothermic, and Cataleptic Effects of Marijuana in Mice

A. Lichtman, B. Thomas, B. Martin, 2005, Journal of Pharmacology and Experimental Therapeutics.

Differential Effects of Delta-9-Tetrahydrocannabinol and Methanandamide in CB 1 Knockout and Wild Type Mice

B. Martin, J. Wiley, 2003 .

Marijuana Withdrawal Syndrome in the Animal Model

A. Lichtman, B. Martin, 2002, Journal of clinical pharmacology.

Identification of the endogenous cannabinoid system through integrative pharmacological approaches.

B. Martin, 2002, The Journal of pharmacology and experimental therapeutics.

Development of agonists, partial agonists and antagonists in the Δ8-Tetrahydrocannabinol series

R. Pertwee, R. Razdan, B. Martin, 1999 .

Effects of SR141716A on Diazepam Substitution for Δ9-Tetrahydrocannabinol in Rat Drug Discrimination

B. Martin, J. Wiley, 1999, Pharmacology Biochemistry and Behavior.

Analgesic Properties of THC and Its Synthetic Derivatives

A. Lichtman, B. Martin, 1999 .

Cannabinoid Transmission and Pain Perception

A. Lichtman, B. Martin, 1998, Neurobiology of Disease.

CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol.

J. Lowe, B. Martin, S. Cook, 1998, The Journal of pharmacology and experimental therapeutics.

CB 1 Receptor Antagonist Precipitates Withdrawal in Mice Exposed to D 9-Tetrahydrocannabinol 1

J. Lowe, B. Martin, S. Cook, 1998 .

Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride].

E. Ellis, B. Martin, A. Shivachar, 1996, Biochemical pharmacology.

Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice

B. Martin, M. Abood, F. Fan, 1996, Brain Research.

Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats

R. L. Barrett, J. Lowe, B. Martin, 1995, Neuropharmacology.

International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

M. Herkenham, F. Barth, M. Herkenham, 2002, Pharmacological Reviews.

D. Selley, B. Martin, J. Wiley, 2008, Journal of Pharmacology and Experimental Therapeutics.

WIN55,212-2-Mediated Inhibition of HIV-1 Expression in Microglial Cells: Involvement of Cannabinoid Receptors

B. Martin, Shuxian Hu, W. Sheng, 2007, Journal of Neuroimmune Pharmacology.

Signaling pathways involved in the development of cannabinoid tolerance.

D. Selley, B. Martin, L. Sim-Selley, 2004, Trends in pharmacological sciences.

Evaluation of Cannabimimetic Discriminative Stimulus Effects of Anandamide and Methylated Fluoroanandamide in Rhesus Monkeys

R. Razdan, B. Martin, W. Ryan, 1997, Pharmacology Biochemistry and Behavior.

Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys.

J. Lowe, B. Martin, J. Wiley, 1995, The Journal of pharmacology and experimental therapeutics.

1-ALKYL-3-(1-NAPHTHOYL)PYRROLES : A NEW CLASS OF CANNABINOID

D. R. Compton, B. Martin, J. Huffman, 1995 .

A comparison of the discriminative stimulus properties of delta 9-tetrahydrocannabinol and CP 55,940 in rats and rhesus monkeys.

R. L. Barrett, L. Gold, B. Martin, 1992, The Journal of pharmacology and experimental therapeutics.

Neurobiology of marijuana abuse.

B. Martin, M. Abood, 1992, Trends in pharmacological sciences.

Studies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol.

J. Scimeca, B. Martin, P. Beardsley, 1987, The Journal of pharmacology and experimental therapeutics.

Marihuana-like activity of new synthetic tetrahydrocannabinols

L. Harris, B. Martin, W. Dewey, 1975, Pharmacology Biochemistry and Behavior.

SR 141716 (Rimonabant) precipitates withdrawal in marijuana-dependent mice

A. Lichtman, B. Martin, David M. Wilson, 2006, Pharmacology Biochemistry and Behavior.

The Potential Role of the Cytochrome P-450 2 D 6 Pharmacogenetic Polymorphism in Drug Abuse

R. Rapaka, B. Martin, N. Chiang, 1997 .

Pharmacological Characterization of Novel Water-Soluble Cannabinoids

R. Razdan, B. Martin, B. Saha, 2006, Journal of Pharmacology and Experimental Therapeutics.

Differential effects of delta 9-THC on spatial reference and working memory in mice.

A. Lichtman, B. Martin, S. Varvel, 2001, Psychopharmacology.

Relation between effects of cannabinoid derivatives on the twitch response of the isolated guinea-pig ileum and their psychotropic properties.

K. Leander, R. Mechoulam, B. Martin, 1978, Advances in the biosciences.

Effects of Cannabinoids on Isolated Smooth Muscle Preparations

B. Martin, S. Rosell, S. Agurell, 1976 .

Modulation of motor and sensory pathways of the peristaltic reflex by cannabinoids.

K. Murthy, S. Mahavadi, J. Kuemmerle, 2009, American journal of physiology. Gastrointestinal and liver physiology.

Delta‐9‐Tetrahydrocannabinol, the Major Psychoactive Component in Marijuana, Inhibits Macrophage Chemotaxis to Acanthamoeba

B. Martin, G. Cabral, F. Marciano-cabral, 2006, The Journal of eukaryotic microbiology.

Pharmacological and behavioral evaluation of alkylated anandamide analogs.

D. R. Compton, R. Razdan, B. Martin, 1995, Life sciences.

Progress toward understanding the cannabinoid receptor and its second messenger systems.

S. Welch, B. Martin, M. Abood, 1994, Advances in pharmacology.

Synthesis and pharmacology of a hybrid cannabinoid.

B. Martin, J. Wiley, J. Huffman, 2000, Bioorganic & medicinal chemistry.

Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy

R. E. Blair, B. Martin, R. Delorenzo, 2007, Neuroscience.

Nicotine-like discriminative stimulus effects of bupropion in rats.

M. Damaj, B. Martin, J. Wiley, 2002, Experimental and clinical psychopharmacology.

Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs.

F. Carroll, M. Damaj, B. Martin, 1999, The Journal of pharmacology and experimental therapeutics.

The spinal cord as a major site for the antinociceptive action of nicotine in the rat

T. Fu, M. Aceto, B. Martin, 1986, Neuropharmacology.

Failure of Δ9‐tetrahydrocannabinol and CP 55,940 to maintain intravenous self‐administration under a fixed‐interval schedule in rhesus monkeys

B. Martin, K. Nicholson, R. Mansbach, 1994, Behavioural pharmacology.

Dependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal.

J. Lowe, M. Aceto, B. Martin, 1996, The Journal of pharmacology and experimental therapeutics.

Discriminative stimulus properties of Δ 9 -Tetrahydrocannabinol (THC) in C57BL/6J mice

J. Warner, B. Martin, J. Wiley, 2009 .

JPET #111625 Cannabimimetic Properties of Ajulemic Acid

B. Martin, J. Wiley, R. Vann, 2006 .

Antinociceptive effects of tetrahydrocannabinol side chain analogs: dependence upon route of administration.

R. Razdan, B. Martin, B. Saha, 2000, European journal of pharmacology.

Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists.

R. Razdan, B. Martin, B. Saha, 1999, The Journal of pharmacology and experimental therapeutics.

Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide.

B. Thomas, R. Pertwee, D. R. Compton, 1997, Journal of medicinal chemistry.

Potent anandamide analogs: the effect of changing the length and branching of the end pentyl chain.

R. Razdan, B. Martin, W. Ryan, 1997, Journal of medicinal chemistry.

Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore.

S. Mascarella, B. Thomas, R. Razdan, 1996, Journal of medicinal chemistry.

Pharmacological specificity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rhesus monkeys.

B. Martin, J. Wiley, R. Balster, 1995, Drug and alcohol dependence.

Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212.

L. Melvin, D. R. Compton, B. Martin, 1994, The Journal of pharmacology and experimental therapeutics.

Behavioral comparisons of the stereoisomers of tetrahydrocannabinols.

L. Harris, R. Razdan, B. Martin, 1981, Life sciences.

A novel class of potent tetrahydrocannabinols (THCS): 2′-YNE-Δ8- and Δ9-THCS

D. R. Compton, R. Razdan, B. Martin, 1995 .

Synthesis and pharmacology of the isomeric methylheptyl-Δ8-tetrahydrocannabinols

J. Liddle, B. Martin, J. Wiley, 1998 .

Side chain methyl analogues of Δ8-THC

D. R. Compton, B. Martin, J. Wiley, 1997 .

Influence of phenylmethylsulfonyl fluoride on anandamide brain levels and pharmacological effects.

K. Willoughby, B. Martin, J. Wiley, 2000, Life sciences.

Interactions between THC and cannabidiol in mouse models of cannabinoid activity

A. Lichtman, B. Martin, J. Wiley, 2006, Psychopharmacology.

Spinal mechanisms of delta 9-tetrahydrocannabinol-induced analgesia.

P. Smith, B. Martin, 1992, Brain research.

Characterization of Spontaneous and Precipitated Nicotine Withdrawal in the Mouse

M. Damaj, B. Martin, W. Kao, 2003, Journal of Pharmacology and Experimental Therapeutics.

Identification of in vitro metabolites of delta 1-tetrahydrocannabinol formed by human livers.

B. Martin, C. Bahr, M. Widman, 1982, Drug metabolism and disposition: the biological fate of chemicals.

3H-delta9-tetrahydrocannabinol distribution in pregnant dogs and their fetuses.

L. Harris, B. Martin, W. Dewey, 1977, Research communications in chemical pathology and pharmacology.

Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents.

M. Johnson, L. Melvin, D. R. Compton, 1992, The Journal of pharmacology and experimental therapeutics.

The antinociceptive effects of intrathecally administered cannabinoids are influenced by lipophilicity

A. Lichtman, B. Martin, Peter B. Smith, 1992, Pain.

The biodisposition and metabolism of anandamide in mice.

E. Ellis, K. Willoughby, B. Martin, 1997, The Journal of pharmacology and experimental therapeutics.

Cocaine inhalation in the rat: pharmacokinetics and cardiovascular response.

W. H. Barr, B. Martin, J. Boni, 1991, The Journal of pharmacology and experimental therapeutics.

Cannabinoid-induced antinociception is mediated by a spinalα2-noradrenergic mechanism

A. Lichtman, B. Martin, 1991, Brain Research.

A computergraphic investigation into the pharmacological role of the THC-cannabinoid phenolic moiety.

S. Semus, B. Martin, 1990, Life sciences.

Pharmacological evaluation of the antagonism of nicotine's central effects by mecamylamine and pempidine.

B. Martin, T. Martin, E. May, 1990, The Journal of pharmacology and experimental therapeutics.

Synthesis and pharmacological characterization of nicotinic acetylcholine receptor properties of (+)- and (-)-pyrido-[3,4-b]homotropanes.

J. Deschamps, H. Navarro, F. Carroll, 2006, Journal of medicinal chemistry.

2-Fluoro-3-(4-nitro-phenyl)deschloroepibatidine Is a Novel Potent Competitive Antagonist of Human Neuronal α4β2 nAChRs

F. Carroll, M. Damaj, B. Martin, 2006, Molecular Pharmacology.

Synthesis and pharmacological characterization of exo-2-(2'-chloro-5-pyridinyl)-7-(endo and exo)-aminobicyclo[2.2.1]heptanes as novel epibatidine analogues.

L. Brieaddy, H. Navarro, F. Carroll, 2005, Journal of medicinal chemistry.

6-(2-Phenylethyl)nicotine: a novel nicotinic cholinergic receptor ligand.

R. Glennon, M. Damaj, R. Young, 2005, Bioorganic & medicinal chemistry letters.

Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted phenyl)deschloroepibatidine analogues. Novel nicotinic antagonist.

L. Brieaddy, H. Navarro, F. Carroll, 2004, Journal of medicinal chemistry.

Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2',3'-disubstituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes: epibatidine analogues.

L. Brieaddy, H. Navarro, F. Carroll, 2001, Journal of medicinal chemistry.

Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted-3'-phenyl-5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Novel nicotinic antagonist.

L. Brieaddy, H. Navarro, F. Carroll, 2001, Journal of medicinal chemistry.

Synthesis and pharmacological properties of 11-hydroxy-3-(1',1'-dimethylheptyl)hexahydrocannabinol: a high-affinity cannabinoid agonist.

A. Makriyannis, D. R. Compton, B. Martin, 1994, Journal of medicinal chemistry.

Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice.

P. Smith, S. Welch, B. Martin, 1994, The Journal of pharmacology and experimental therapeutics.

Pharmacological evaluation of iodo and nitro analogs of Δ 8-THC and Δ 9-THC

S. Semus, Sonyuan Lin, J. Grzybowska, 1993, Pharmacology Biochemistry and Behavior.

Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol.

C. Siegel, D. R. Compton, R. Razdan, 1991, Journal of medicinal chemistry.

Synthesis and pharmacological evaluation of amino, azido, and nitrogen mustard analogues of 10-substituted cannabidiol and 11- or 12-substituted delta 8-tetrahydrocannabinol.

P. Little, D. R. Compton, R. Razdan, 1990, Journal of medicinal chemistry.

Synthesis and pharmacological evaluation of mercapto and thioacetyl analogues of cannabidiol and Δ8-tetrahydrocannabinol

P. Little, D. R. Compton, R. Razdan, 1989 .

Evaluation of cannabimimetic effects of structural analogs of anandamide in rats.

R. Razdan, B. Martin, W. Ryan, 1998, European journal of pharmacology.

Enantiomeric N-substituted N-normetazocines: a comparative study of affinities at sigma, PCP, and mu opioid receptors.

S. Mascarella, F. Carroll, B. Martin, 1992, Journal of medicinal chemistry.

Age-dependent differences in nicotine reward and withdrawal in female mice

M. Damaj, B. Martin, B. R. Martin, 2008, Psychopharmacology.

Nicotine-induced antinociception in rats and mice: correlation with nicotine brain levels.

M. Aceto, B. Martin, H. Tripathi, 1982, The Journal of pharmacology and experimental therapeutics.

Is the dopaminergic system involved in the central effects of nicotine in mice?

M. Damaj, B. Martin, 2005, Psychopharmacology.

International Cannabis Research Society meeting summary, Keystone, CO (June 19-20, 1992).

S. Deadwyler, R. Mechoulam, B. Martin, 1993, Drug and alcohol dependence.

Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol.

J. Warner, B. Martin, J. Wiley, 2008, Drug and alcohol dependence.

Distribution of radioactivity in the spinal cord after intracerebroventricular and intravenous injection of radiolabeled opioid peptides in mice.

T. Fu, B. Martin, W. Dewey, 1982, Journal of Pharmacology and Experimental Therapeutics.

Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice.

R. Glennon, M. Damaj, B. Martin, 1998, The Journal of pharmacology and experimental therapeutics.

Some 11-substituted tetrahydrocannabinols. Synthesis and comparison with the potent cannabinoid metabolites 11-hydroxytetrahydrocannabinols.

B. Martin, W. Dewey, R. Wilson, 1979, Journal of medicinal chemistry.

Pharmacology of lobeline, a nicotinic receptor ligand.

M. Damaj, B. Martin, G. Patrick, 1997, The Journal of pharmacology and experimental therapeutics.

Design, synthesis and pharmacology of cannabimimetic indoles

John W. Huffman, D. R. Compton, B. Martin, 1994 .

Pyrrolidine-modified and 6-substituted analogs of nicotine: A structure—affinity investigation

R. Glennon, B. Martin, M. Dukat, 1996 .

The Synthesis of N-Vanillyl-arachidonoyl-amide (Arvanil) and its Analogs: An Improved Procedure for the Synthesis of the Key Synthon Methyl 14-Hydroxy-(all-cis)-5,8,11-tetradecatrienoate

V. Marzo, R. Razdan, B. Martin, 2000 .

Hashish: synthesis and central nervous system activity of some novel analogues of cannabidiol and oxepin derivatives of delta 9-tetrahydrocannabinol.

L. Harris, R. Razdan, B. Martin, 1985, Journal of medicinal chemistry.

Pharmacological effects of 1,2,3,5,6,10b-hexahydropyrido[2,3g]indolizine, a bridged-nicotine analog.

M. Aceto, B. Martin, J. Egle, 1986, Life sciences.

Synthesis of 4,4-ditritio-(+)-nicotine: comparative binding and distribution studies with natural enantiomer.

M. Aceto, L. Harris, B. Martin, 1981, Journal of pharmaceutical sciences.

Antinociceptive and pharmacological effects of metanicotine, a selective nicotinic agonist.

M. Aceto, M. Damaj, B. Martin, 1999, The Journal of pharmacology and experimental therapeutics.

Relationship between the biodisposition of [3H]soman and its pharmacological effects in mice.

P. Little, B. Thomas, B. Martin, 1985, Toxicology and applied pharmacology.

Antinociceptive action of nicotine and its methiodide derivatives in mice and rats

M. Aceto, B. Martin, E. May, 1983, British journal of pharmacology.

Binding of nicotine and homoazanicotine analogues at neuronal nicotinic acetylcholinergic (nACh) receptors.

R. Glennon, M. Damaj, B. Martin, 2003, Bioorganic & medicinal chemistry letters.

Quaternary ammonium 3-(aminoethoxy)pyridines as antinociceptive agents.

R. Glennon, B. Martin, M. Dukat, 2003, Bioorganic & medicinal chemistry letters.

Nicotine-induced antinociception in mice: Role of G-proteins and adenylate cyclase

M. Damaj, S. Welch, B. Martin, 1994, Pharmacology Biochemistry and Behavior.

Modification of pentobarbital effects by natural and synthetic polypeptides: dissociation of brain and pituitary effects.

C. Nemeroff, B. Cooper, G. Breese, 1975, Life sciences.

The antinociceptive effects of α7 nicotinic agonists in an acute pain model

E. Meyer, M. Damaj, B. Martin, 2000, Neuropharmacology.

The antinociceptive effects of alpha7 nicotinic agonists in an acute pain model.

E. Meyer, M. Damaj, B. Martin, 2000, Neuropharmacology.

Endocannabinoids in cognition and dependence.

A. Lichtman, B. Martin, S. Varvel, 2002, Prostaglandins, leukotrienes, and essential fatty acids.

Cannabis: pharmacology and toxicology in animals and humans.

B. Martin, I. B. Adams, B R Martin, 1996, Addiction.

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.

T. Bonner, A. Zimmer, É. Mezey, 1999, Proceedings of the National Academy of Sciences of the United States of America.

What is the nature of mecamylamine's antagonism of the central effects of nicotine?

B. Martin, T. Martin, E. Onaivi, 1989, Biochemical pharmacology.

Prolonged exposure to WIN55,212-2 causes downregulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects in the hippocampal neuronal culture model of acquired epilepsy

S. Sombati, M. Elphick, B. Martin, 2009, Neuropharmacology.

Endocannabinoids block status epilepticus in cultured hippocampal neurons.

S. Sombati, B. Martin, R. Delorenzo, 2007, European journal of pharmacology.

Distribution of [3H]diisopropylfluorophosphate, [3H]soman, [3H]sarin, and their metabolites in mouse brain.

P. Little, J. Scimeca, B. Martin, 1988, Drug Metabolism And Disposition.

Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice.

J. Warner, B. Martin, J. Wiley, 2009, European journal of pharmacology.

The Endogenous Cannabinoid System Regulates Seizure Frequency and Duration in a Model of Temporal Lobe Epilepsy

B. Martin, R. Delorenzo, K. W. Falenski, 2003, Journal of Pharmacology and Experimental Therapeutics.

Differential effects of Δ9-THC on spatial reference and working memory in mice

A. Lichtman, B. Martin, S. Varvel, 2001, Psychopharmacology.

Pharmacological effects of methamphetamine and other stimulants via inhalation exposure.

A. Lichtman, B. Martin, M. Dukat, 1999, Drug and Alcohol Dependence.

Acute tolerance to the cardiovascular effects of volatilized cocaine free base in rats.

A. Lichtman, B. Martin, P. Sathe, 1995, Drug and alcohol dependence.

Spinal action of cannabinoid-induced antinociception.

A. Lichtman, B. Martin, 1990, NIDA research monograph.

The disposition of [3H]diisopropylfluorophosphate in guinea pigs after inhalation.

J. Scimeca, B. Martin, 1988, Drug metabolism and disposition: the biological fate of chemicals.

Relationship between the pharmacological effects and the biodisposition of [3H]diisopropylfluorophosphate in mice after inhalation.

P. Little, J. Scimeca, B. Martin, 1985, Toxicology and applied pharmacology.

Biodisposition of [3H]diisopropylfluorophosphate in mice.

B. Martin, 1985, Toxicology and applied pharmacology.

Antipodal alpha-N-(methyl through decyl)-N-normetazocines (5,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphans): in vitro and in vivo properties.

M. Aceto, L. Harris, B. Martin, 1994, Journal of medicinal chemistry.

Multiple populations of serotonin receptors may modulate the behavioral effects of serotonergic agents.

R. Glennon, B. Martin, N. Darmani, 1991, Life sciences.

In vitro metabolism of (-)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl) phenyl]-trans-4-(3-hydroxypropyl) cyclohexanol, a synthetic bicyclic cannabinoid analog.

B. Thomas, B. Martin, 1990, Drug metabolism and disposition: the biological fate of chemicals.

Structural requirements for cannabinoid-induced antinociceptive activity in mice.

B. Martin, 1985, Life sciences.

Nicotine Dependence and Reward Differ between Adolescent and Adult Male Mice

S. Robinson, M. Damaj, B. Martin, 2007, Journal of Pharmacology and Experimental Therapeutics.

The Endogenous Cannabinoid System Modulates Nicotine Reward and Dependence

A. Lichtman, M. Damaj, B. Martin, 2008, Journal of Pharmacology and Experimental Therapeutics.

Long-Term Administration of Δ9-Tetrahydrocannabinol Desensitizes CB1-, Adenosine A1-, and GABAB-Mediated Inhibition of Adenylyl Cyclase in Mouse Cerebellum

D. Selley, B. Martin, M. Cassidy, 2004, Molecular Pharmacology.

Inhibition of Adenylyl Cyclase in Mouse Cerebellum

D. Selley, B. Martin, M. Cassidy, 2004 .

Inhalation exposure to volatilized opioids produces antinociception in mice.

A. Lichtman, B. Martin, Y. Meng, 1996, The Journal of pharmacology and experimental therapeutics.

Pharmacological potency and biodisposition of phencyclidine via inhalation exposure in mice.

A. Lichtman, B. Martin, D. Bridgen, 1996, Drug and alcohol dependence.

Methcathinone (“cat”): An enantiomeric potency comparison

R. Glennon, R. Young, B. Martin, 1995, Pharmacology Biochemistry and Behavior.

Marijuana: Pharmacology and Interaction with the Endocannabinoid System

B. Martin, J. Wiley, 2007 .

Effects of the cannabinoid CB1 receptor antagonist, SR141716A, after Δ9-tetrahydrocannabinol withdrawal

B. Martin, P. Beardsley, 2000 .

Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine.

A. Lichtman, B. Martin, J. Fisher, 2001, Pharmacology, biochemistry, and behavior.

Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice.

C. Bass, B. Martin, 2000, Drug and alcohol dependence.

Cannabis dependence and tolerance production.

D. R. Compton, B. Martin, W. Dewey, 1990, Advances in alcohol & substance abuse.

Characterization of the interaction of pentazocine and tripelennamine: Drug discrimination and mu-receptor binding assay

B. Martin, W. Dewey, J. Shook, 1984, Pharmacology Biochemistry and Behavior.

Cannabis produces dependence: a comment on Smith.

B. Martin, 2002, Addiction.

College on problems of drug dependence meeting, Puerto Rico (June 1996) marijuana use and dependence.

D. Kandel, A. Budney, R. Stephens, 1997, Drug and Alcohol Dependence.

Chain-lengthened and imidazoline analogues of nicotine.

R. Glennon, M. Damaj, B. Martin, 2000, Bioorganic & medicinal chemistry letters.

Thyroid-imipramine clinical and chemical interaction: evidence for a receptor deficit in depression.

G. Breese, M. Lipton, A. Prange, 1972, Journal of psychiatric research.

Antinociceptive effects of supraspinal rat cart (55–102) peptide in mice

M. Kuhar, M. Damaj, B. Martin, 2003, Brain Research.

Stereoselectivity of Nicotine’s Central Effects and Its Relationship to Pain and Cardiovascular Function

B. Martin, 1987 .

3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor.

S. Yu, J. Liddle, B. Martin, 1999, Bioorganic & medicinal chemistry.

Stereoselective synthesis of the epimeric Δ7-tetrahydrocannabinols

D. R. Compton, B. Martin, P. Reggio, 1995 .

Optically pure (+)-nicotine from (+/-)-nicotine and biological comparisons with (-)-nicotine.

M. Aceto, L. Harris, B. Martin, 1979, Journal of medicinal chemistry.

Calcium agonists and antagonists of the dihydropyridine type: effect on nicotine-induced antinociception and hypomotility.

M. Damaj, B. Martin, 1993, Drug and alcohol dependence.

Prolonged Recovery Rate of CB1 Receptor Adaptation after Cessation of Long-Term Cannabinoid Administration

D. Selley, B. Martin, George D. Dalton, 2006, Molecular Pharmacology.

Pharmacological characterization of nicotine-induced seizures in mice.

M. Damaj, B. Martin, M. Dukat, 1999, The Journal of pharmacology and experimental therapeutics.

Relationship of the biodisposition of the stereoisomers of nicotine in the central nervous system to their pharmacological actions.

M. Aceto, B. Martin, H. Tripathi, 1983, The Journal of pharmacology and experimental therapeutics.

A Convenient Method for the Preparation of Racemic Nicotine

B. Martin, E. Bowman, H. McKennis, 1983 .

The Effect of Acute Dyflos (DFP) Treatment on [3H]Nicotine Binding to Mouse Brain Homogenate

J. Scimeca, B. Martin, 1988, The Journal of pharmacy and pharmacology.

Nicotine binding sites and their localization in the central nervous system

M. Aceto, B. Martin, 1981, Neuroscience & Biobehavioral Reviews.

Synthesis and preliminary binding studies of 4,4-ditritio-(-)-nicotine of high specific activity.

M. Aceto, B. Martin, E. Bowman, 1980, Journal of medicinal chemistry.

Inhibition of Nicotine Metabolism by Methoxysalen: Pharmacokinetic and Pharmacological Studies in Mice

R. Tyndale, E. Sellers, M. Damaj, 2007, Journal of Pharmacology and Experimental Therapeutics.

Effect of Dextrometorphan and Dextrorphan on Nicotine and Neuronal Nicotinic Receptors: In Vitro and in Vivo Selectivity

P. Flood, M. Damaj, B. Martin, 2005, Journal of Pharmacology and Experimental Therapeutics.

Enantioselective Effects of Hydroxy Metabolites of Bupropion on Behavior and on Function of Monoamine Transporters and Nicotinic Receptors

R. Lukas, H. Navarro, F. Carroll, 2004, Molecular Pharmacology.

Nicotine-like discriminative stimulus effects of bupropion in rats.

M. Damaj, B. Martin, J. Wiley, 2002, Experimental and clinical psychopharmacology.

Bupropion is a nicotinic antagonist.

M. Damaj, B. Martin, J. Slemmer, 2000, The Journal of pharmacology and experimental therapeutics.

Pharmacological investigation of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H-pyrrolo-[3,2-h]isoq uinoline, a bridged-nicotine analog.

J. R. James, A. Collins, M. Marks, 1997, The Journal of pharmacology and experimental therapeutics.

Pharmacology of Lobeline , A Nicotinic Receptor Ligand 1

M. Damaj, B. Martin, G. Patrick, 1997 .

Involvement of the serotonergic system in the hypoactive and antinociceptive effects of nicotine in mice

R. Glennon, M. Damaj, B. Martin, 1994, Brain Research Bulletin.

Pharmacological effects of epibatidine optical enantiomers

M. Damaj, B. Martin, J. Rosecrans, 1994, Brain Research.

Evidence that the antinociceptive tail-flick response is produced independently from changes in either tail-skin temperature or core temperature

A. Lichtman, B. Martin, Forrest L. Smith, 1993, Pain.

Involvement of calcium and L-type channels in nicotine-induced antinociception.

M. Damaj, S. Welch, B. Martin, 1993, The Journal of pharmacology and experimental therapeutics.

Synthesis of 2-exo- and 2-endo-mecamylamine analogues. Structure-activity relationships for nicotinic antagonism in the central nervous system.

B. Martin, C. George, E. May, 1991, Journal of medicinal chemistry.

Cardiovascular effects of Δ9- andΔ9(11)-tetrahydrocannabinol and their interaction with epinephrine

B. Martin, W. Dewey, D. Brase, 1987 .

Pharmacological potency of R- and S-3′-hydroxy-Δ9-tetrahydrocannabinol: additional structural requirement for cannabinoid activity

L. Harris, R. Razdan, B. Martin, 1984, Pharmacology Biochemistry and Behavior.

Repeated administration of low doses of cocaine enhances the sensitivity of 5-HT2 receptor function

R. Glennon, B. Martin, N. Darmani, 1992, Pharmacology Biochemistry and Behavior.

Inhibition of 5-HT2 receptor-mediated head-twitch response by cocaine via indirect stimulation of adrenergic α 2 and serotonergic 5-HT1A receptors

R. Glennon, B. Martin, N. Darmani, 1991, Pharmacology Biochemistry and Behavior.

Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes.

B. Martin, J. Wiley, 2002, Chemistry and physics of lipids.

Symposium overview: mechanism of action of nicotine on neuronal acetylcholine receptors, from molecule to behavior.

E. Levin, D. Sattelle, R. Lester, 2000, Toxicological sciences : an official journal of the Society of Toxicology.

Comparative pharmacology of nicotine and ABT-418, a new nicotinic agonist

M. Aceto, M. Damaj, S. Welch, 1995, Psychopharmacology.

Discriminative stimulus properties and brain distribution of phencyclidine in rats following administration by injection and smoke inhalation

B. Martin, R. Balster, W. D. Wessinger, 1985, Pharmacology Biochemistry and Behavior.

Do functional relationships exist between 5-HT1A and 5-HT2 receptors?

R. Glennon, B. Martin, N. Darmani, 1990, Pharmacology Biochemistry and Behavior.

Inhalation studies with drugs of abuse.

A. Lichtman, B. Martin, D. Bridgen, 1997, NIDA research monograph.

Modification of phencyclidine intoxification and biodisposition by charcoal and other treatments

B. Thomas, D. R. Compton, B. Martin, 1988, Pharmacology Biochemistry and Behavior.

Relationship between the development of behavioral tolerance and the biodisposition of phencyclidine in mice

A. S. Freeman, B. Martin, R. Balster, 1984, Pharmacology Biochemistry and Behavior.

Interactions between phencyclidine and Δ9-tetrahydrocannabinol in mice following smoke exposure

A. S. Freeman, B. Martin, 1983 .

Disposition of phencyclidine in mice after smoke exposure.

A. S. Freeman, B. Martin, 1982, Drug metabolism and disposition: the biological fate of chemicals.

Modification of the behavioral effects of phencyclidine by repeated drug exposure and body weight changes

B. Martin, W. Woolverton, R. Balster, 1980, Pharmacology Biochemistry and Behavior.

Studies on the disposition of phencyclidine in mice.

B. Martin, R. Balster, W. Vincek, 1980, Drug metabolism and disposition: the biological fate of chemicals.

Thyroid-Imipramine Interaction: Clinical Results and Basic Mechanism

G. Breese, M. Lipton, A. Prange, 1971 .

Quantification of phencyclidine in mainstream smoke and identification of phenylcyclohex-1-ene as pyrolysis product.

A. S. Freeman, B. Martin, 1981, Journal of pharmaceutical sciences.

A comparison of the binding of three series of nicotinic ligands.

R. Glennon, M. Damaj, B. Martin, 2002, Bioorganic & medicinal chemistry letters.

A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats.

R. Razdan, B. Martin, Sanjitha Kulasegram, 2004, Experimental and clinical psychopharmacology.

Role of lipids and lipid signaling in the development of cannabinoid tolerance.

B. Martin, 2005, Life sciences.

Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity.

B. Martin, R. Delorenzo, M. J. Wallace, 2002, European journal of pharmacology.

Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects.

B. Martin, J. Wiley, R. Delorenzo, 2001, European journal of pharmacology.

The role of various nicotinic receptor subunits and factors influencing nicotine conditioned place aversion

M. Damaj, B. Martin, K. Jackson, 2009, Neuropharmacology.

Temporal characterization of changes in hippocampal cannabinoid CB1 receptor expression following pilocarpine-induced status epilepticus

B. Martin, R. Delorenzo, K. W. Falenski, 2009, Brain Research.

Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy

S. Sombati, B. Martin, R. Delorenzo, 2007, Neuroscience Letters.

Development of pharmacoresistance to benzodiazepines but not cannabinoids in the hippocampal neuronal culture model of status epilepticus

S. Sombati, B. Martin, R. Delorenzo, 2007, Experimental Neurology.

The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity.

D. R. Compton, B. Martin, 1997, The Journal of pharmacology and experimental therapeutics.

CB1 cannabinoid receptor‐mediated modulation of food intake in mice

J. Burston, R. Razdan, B. Martin, 2005, British journal of pharmacology.

Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide.

C. Breivogel, T. Bisogno, V. Marzo, 2000, European journal of pharmacology.

Nicotine physical dependence and tolerance in the mouse following chronic oral administration

R. Tyndale, E. Sellers, M. Damaj, 2005, Psychopharmacology.

Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5'-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes.

G. Griffin, B. Martin, V. Showalter, 1998, The Journal of pharmacology and experimental therapeutics.

Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.

D. R. Compton, B. Martin, I. B. Adams, 1998, The Journal of pharmacology and experimental therapeutics.

1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice.

B. Martin, J. Wiley, J. Huffman, 2012, Drug and alcohol dependence.

Pharmacological specificity of Δ9-tetrahydrocannabinol discrimination in rats

B. Martin, J. Wiley, Robert Barrett, 1995, Psychopharmacology.

Integration of Molecular and Behavioral Approaches to Evaluate Cannabinoid Dependence

D. Selley, A. Lichtman, B. Martin, 2003 .

Assessment of structural commonality between tetrahydrocannabinol and anandamide.

B. Thomas, R. Razdan, B. Martin, 2002, European journal of pharmacology.

Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum

G. Griffin, B. Martin, M. Abood, 1999, British journal of pharmacology.

The Selective Cannabinoid Antagonist SR 141716A Blocks Cannabinoid-Induced Antinociception in Rats

A. Lichtman, B. Martin, 1997, Pharmacology Biochemistry and Behavior.

Cannabinoid receptors in developing rats: detection of mRNA and receptor binding.

D. R. Compton, B. Martin, M. Abood, 1994, Drug and alcohol dependence.

Intrathecal CART (55–102) attenuates hyperlagesia and allodynia in a mouse model of neuropathic but not inflammatory pain

M. Kuhar, M. Damaj, B. Martin, 2006, Peptides.

Unique analogues of anandamide: arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas.

R. Razdan, B. Martin, M. Abood, 1999, Journal of medicinal chemistry.

Synthesis, nicotinic acetylcholine receptor binding, and pharmacological properties of 3'-(substituted phenyl)deschloroepibatidine analogs.

F. Ivy Carroll, L. Brieaddy, H. Navarro, 2008, Bioorganic & medicinal chemistry.

Synthesis, optical resolution, absolute configuration, and preliminary pharmacology of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H- pyrrolo-[3,2-h]isoquinoline, a structural analog of nicotine.

B. Martin, C. George, E. May, 1993, Journal of medicinal chemistry.

malignant lymphoblastic disease Targeting CB2 cannabinoid receptors as a novel therapy to treat

Michael T. Fisher, M. Nagarkatti, P. Nagarkatti, 2013 .

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.

Michael T. Fisher, M. Nagarkatti, P. Nagarkatti, 2002, Blood.

Cannabinoid tolerance and dependence.

A. Lichtman, B. Martin, Billy R. Martin, 2005, Handbook of experimental pharmacology.

Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB(1) receptor antagonist.

C. Breivogel, M. Cascio, D. Bolognini, 2011, European journal of pharmacology.

Cannabinoid pharmacological properties common to other centrally acting drugs.

B. Martin, J. Wiley, 2003, European journal of pharmacology.

Discriminative stimulus effects of Δ 9-tetrahydrocannabinol and Δ 9–11-tetrahydrocannabinol in rats and rhesus monkeys

R. L. Barrett, B. Martin, J. Wiley, 1993, Neuropharmacology.

Discriminative stimulus effects of delta 9-tetrahydrocannabinol and delta 9-11-tetrahydrocannabinol in rats and rhesus monkeys.

R. L. Barrett, B. Martin, J. Wiley, 1993, Neuropharmacology.

A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid.

T. Bisogno, M. Grier, V. Di Marzo, 2002, The Journal of pharmacology and experimental therapeutics.

Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands.

L. Petrocellis, T. Bisogno, V. Di Marzo, 2001, Biochemical and biophysical research communications.

Δ9-Tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism

A. Lichtman, B. Martin, A. H. Lichtman, 1996, Psychopharmacology.

Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats

A. Lichtman, B. Martin, A. H. Lichtman, 1995, Psychopharmacology.

Effects of SR 141716A after acute or chronic cannabinoid administration in dogs.

A. Lichtman, B. Martin, J. Wiley, 1998, European journal of pharmacology.

Synthesis of (+)- and (-)-2-methylarachidonyl-2'-fluoroethylamide (O-689)

R. Razdan, B. Martin, W. Ryan, 1997 .

Characterization of pharmacological and behavioral differences to nicotine in C57Bl/6 and DBA/2 mice

M. Miles, M. Damaj, B. Martin, 2009, Neuropharmacology.

Enzymatic hydrolysis of 3-methoxy-4-hydroxyphenethyl-eneglycol conjugates.

B. Martin, A. Prange, M. Timmons, 1972, Clinica chimica acta; international journal of clinical chemistry.

Plasma concentrations of delta-9-tetrahydrocannabinol in dams and fetuses following acute or multiple prenatal dosing in rats.

B. Martin, D. Hutchings, Z. Gamagaris, 1989, Life sciences.

Behavioral effects in the mouse during and following withdrawal from ethanol ingestion and/or nicotine administration.

B. Martin, E. Onaivi, S. Todd, 1989, Drug and alcohol dependence.

Acute and chronic effects of cocaine on isolation-induced aggression in mice

W. H. Carter, B. Martin, N. Darmani, 2005, Psychopharmacology.

Tissue disposition of [3H]sarin and its metabolites in mice.

P. Little, B. Martin, E. Bowman, 1986, Toxicology and applied pharmacology.

Interactions of thyrotropin releasing hormone and morphine sulfate in rodents.

A. Prange, B. Martin, W. Dewey, 1977, Life sciences.

Intrathecal CART (55-102) enhances the spinal analgesic actions of morphine in mice

M. Kuhar, M. Damaj, B. Martin, 2004, Brain Research.

Clinical Consequences of Marijuana

B. Martin, J. Khalsa, S. Genser, 2002, Journal of clinical pharmacology.

Effects of systemic and intraventricular administration of cannabinoids on schedule-controlled responding in the squirrel monkey.

L. Harris, J. Carney, B. Martin, 1979, The Journal of pharmacology and experimental therapeutics.

Identification of metabolites of Δ1‐ and Δ1(6)‐tetrahydrocannabinol containing a reduced double bond

W. Paton, D. Harvey, B. Martin, 1977 .

Biotransformation of cannabidiol in mice. Identification of new acid metabolites.

W. Paton, D. Harvey, B. Martin, 1977, Drug metabolism and disposition: the biological fate of chemicals.

Characterization of in Vivo Liver Metabolites of Δ1-Tetrahydrocannabinol by Ei and Ci Mass Spectrometry

W. Paton, D. Harvey, B. Martin, 1977 .

Dioxygenated metabolites of cannabidiol formed by rat liver

B. Martin, S. Agurell, M. Nordqvist, 1976, The Journal of pharmacy and pharmacology.

Pharmacological evaluation of water soluble cannabinoids and related analogs.

D. R. Compton, B. Martin, 1990, Life sciences.

PHARMACOLOGICAL ACTIVITY OF DELTA-9-THC METABOLITES AND ANALOGS OF CBD, DELTA-8-THC AND DELTA-9-THC*

L. Harris, B. Martin, W. Dewey, 1984 .

3H-delta9-tetrahydrocannabinol tissue and subcellular distribution in the central nervous system and tissue distribution in peripheral organs of tolerant and nontolerant dogs.

L. Harris, B. Martin, W. Dewey, 1976, The Journal of pharmacology and experimental therapeutics.

In vivo metabolism of cannabinol by the mouse and rat and a comparison with the metabolism of Δ1‐tetrahydrocannabinol and cannabidiol

W. Paton, D. Harvey, B. Martin, 1977 .

Identification and measurement of cannabinoids and their in vivo metabolites in liver by gas chromatography--mass spectrometry.

W. Paton, D. Harvey, B. Martin, 1978, Advances in the biosciences.

Comparative in vivo Metabolism of Δ1-tetrahydrocannabinol (Δ1-THC), cannabidiol (CBD) and cannabinol (CBN) by Several Species

W. Paton, D. Harvey, B. Martin, 1978 .

Behavioral evidence for differential adaptation of the serotonergic system after acute and chronic treatment with (+/- )-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) or ketanserin.

R. Glennon, B. Martin, N. Darmani, 1992, The Journal of pharmacology and experimental therapeutics.

Withdrawal from chronic treatment with (+/-)-DOI causes super-sensitivity to 5-HT2 receptor-induced head-twitch behaviour in mice.

R. Glennon, B. Martin, N. Darmani, 1990, European journal of pharmacology.

Pharmacological characterization of ear-scratch response in mice as a behavioral model for selective 5-HT2-receptor agonists and evidence for 5-HT1B- and 5-HT2-receptor interactions

R. Glennon, B. Martin, N. Darmani, 1990, Pharmacology Biochemistry and Behavior.

Neuropharmacological and physiological validation of a computer-controlled two-compartment black and white box for the assessment of anxiety

B. Martin, E. Onaivi, 1989, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Contemporary Drug Abuse

B. Martin, W. Dewey, 2003 .

Evidence for the existence of specific cannabinoid binding sites.

R. Carchman, L. Harris, B. Martin, 1978, Life sciences.

SR-141716A-induced stimulation of locomotor activity A structure–activity relationship study

C. Bass, M. Grier, G. Griffin, 2002, Pharmacology Biochemistry and Behavior.

Cardiovascular effects of delta 9- and delta 9(11)-tetrahydrocannabinol and their interaction with epinephrine.

B. Martin, W. Dewey, D. Brase, 1987, Life Science.

Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-substituted deschloroepibatidine analogues. Novel nicotinic antagonists.

L. Brieaddy, H. Navarro, F. Carroll, 2005, Journal of medicinal chemistry.

Identification of glucuronides as in vivo liver conjugates of seven cannabinoids and some of their hydroxy and acid metabolites.

W. Paton, D. Harvey, B. Martin, 1977, Research communications in chemical pathology and pharmacology.

QSAR analysis of Delta(8)-THC analogues: relationship of side-chain conformation to cannabinoid receptor affinity and pharmacological potency.

S. Mascarella, B. Thomas, R. Razdan, 2000, Journal of medicinal chemistry.

Effects of the cannabinoid CB(1) receptor antagonist, SR141716A, after Delta(9)-tetrahydrocannabinol withdrawal.

B. Martin, P. Beardsley, 2000, European Journal of Pharmacology.

Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors.

B. Cravatt, L. Wise, A. Lichtman, 2007, European journal of pharmacology.

Evaluation of the role of the arachidonic acid cascade in anandamide's in vivo effects in mice.

R. Razdan, B. Martin, J. Wiley, 2006, Life sciences.

Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor.

D. R. Compton, B. Martin, J. Wiley, 1996, Journal of medicinal chemistry.

(+)- and (-)-N-allylnormetazocine binding sites in mouse brain: in vitro and in vivo characterization and regional distribution.

D. R. Compton, B. Martin, J. Katzen, 1987, Life sciences.

Neurochemical and behavioral effects of polychlorinated biphenyls in mice.

B. Martin, D. Rosin, 1981, Neurotoxicology.

Novel cannabinol probes for CB1 and CB2 cannabinoid receptors.

C. Siegel, R. Razdan, B. Martin, 2000, Journal of medicinal chemistry.

The appearance of endogenous opiates in cerebrospinal fluid following opiate injection in various animal species.

S. Welch, B. Martin, E. Bowman, 1982, Life sciences.

3H-Δ9-tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: Penetration and regional distribution in rat brain

L. Harris, B. Martin, W. Dewey, 1980, Pharmacology, Biochemistry and Behavior.

Characterization and modulation of acute tolerance to nicotine in mice.

M. Damaj, S. Welch, B. Martin, 1996, The Journal of pharmacology and experimental therapeutics.

Opioid and Nonopioid Analgesics

S. Welch, B. Martin, 2003 .

A rational search for the separation of psychoactivity and analgesia in cannabinoids

G. McGaughey, D. R. Compton, B. Martin, 1991, Pharmacology Biochemistry and Behavior.

Genetic approaches identify differential roles for alpha4beta2* nicotinic receptors in acute models of antinociception in mice.

A. C. Collins, H. Lester, A. Collins, 2007, The Journal of pharmacology and experimental therapeutics.

(+/-)8-Amino-5,6,7,8-tetrahydroisoquinolines as novel antinociceptive agents.

R. Glennon, M. Damaj, B. Martin, 2004, Bioorganic & Medicinal Chemistry Letters.

Nicotine physical dependence in the mouse : Involvement of the α7 nicotinic receptor subtype

B. Martin, Sheri D. Grabus, M. Imad Damaj, 2005 .

Reversal of delta 9-tetrahydrocannabinol-induced tolerance by specific kinase inhibitors.

C. Bass, S. Welch, B. Martin, 2004, European Journal of Pharmacology.

Lack of behavioral sensitization after repeated exposure to THC in mice and comparison to methamphetamine

A. Lichtman, B. Martin, Stephen A. Varvel, 2007, Psychopharmacology.

A novel class of potent tetrahydrocannabinols (THCS): 2'-yne-delta 8- and delta 9-THCS.

D. R. Compton, R. Razdan, B. Martin, 1995, Life sciences.

A cannabinoid with cardiovascular activity but no overt behavioral effects

L. Harris, R. Razdan, B. Martin, 1977, Experientia.

Pharmacological specificity of delta 9-tetrahydrocannabinol discrimination in rats.

R. L. Barrett, B. Martin, J. Wiley, 1995, Psychopharmacology.

A Comparison of the Subcellular Distribution of Cannabinoids in the Brains of Tolerant and Nontolerant Dogs, Rats, and Mice After Injecting Radiolabeled Δ9-Tetrahydrocannabinol

L. Harris, B. Martin, W. Dewey, 1976 .

Pyrolytic fate of piperidinocyclohexanecarbonitrile, a contaminant of phencyclidine, during smoking.

B. Thomas, J. Scimeca, B. Martin, 1988, Journal of analytical toxicology.

Identification and quantification of phencyclidine pyrolysis products formed during smoking.

B. Thomas, J. Scimeca, B. Martin, 1986, Journal of analytical toxicology.

Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by Δ9-THC in the rat

L. Gold, B. Martin, W. R. Prescott, 2005, Psychopharmacology.

Novel pyrazole cannabinoids: insights into CB(1) receptor recognition and activation.

M. Grier, R. Razdan, B. Martin, 2001, The Journal of pharmacology and experimental therapeutics.

Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-(substituted phenyl)epibatidine analogues. Nicotinic partial agonists.

H. Navarro, F. Carroll, M. Damaj, 2010, Journal of natural products.

Cannabinoid-induced antinociception is mediated by a spinal alpha 2-noradrenergic mechanism.

A. Lichtman, B. Martin, 1991, Brain research.

International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

M. Herkenham, K. Mackie, T. Bonner, 2002, Pharmacological Reviews.

(-)6-n-Propylnicotine antagonizes the antinociceptive effects of (-)nicotine.

R. Glennon, M. Damaj, R. Young, 2002, Bioorganic & medicinal chemistry letters.

9-Nor-9-hydroxyhexahydrocannabinols. Synthesis, Some behavioral and analgesic properties, and comparison with the tetrahydrocannabinols.

B. Martin, W. Dewey, E. May, 1976, Journal of medicinal chemistry.

The Synthesis of N‐Vanillyl‐arachidonoyl‐amide (Arvanil) and Its Analogues: An Improved Procedure for the Synthesis of the Key Synthon Methyl 14‐Hydroxy‐(all‐cis)‐5,8,11‐tetradecatrienoate.

V. Marzo, R. Razdan, B. Martin, 2001 .

Short communication Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB 1 receptors

B. Cravatt, L. Wise, A. Lichtman, 2007 .

Comparison of the effects of acute and subchronic administration of Aroclor 1254, a commercial mixture of polychlorinated biphenyls, on pentobarbital-induced sleep time and [14C]pentobarbital disposition in mice.

B. Martin, D. Rosin, 1983, Journal of toxicology and environmental health.

3'-Hydroxy- and (+/-)-3',11-dihydroxy-delta 9-tetrahydrocannabinol: biologically active metabolites of delta 9-tetrahydrocannabinol.

L. Harris, R. Razdan, B. Martin, 1982, Journal of medicinal chemistry.

Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs.

P. Little, R. Mechoulam, D. R. Compton, 1989, Pharmacology, biochemistry, and behavior.

3-(2-Aminoethyl)pyridine analogs as α4β2 nicotinic cholinergic receptor ligands

R. Glennon, R. Banzi, M. Damaj, 2005 .